Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigens.

@article{Farina1996ConservedTU,
  title={Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigens.},
  author={Cinthia Farina and Pierre van der Bruggen and Pascale Bo{\"e}l and Giorgio Parmiani and Marialuisa Sensi},
  journal={International immunology},
  year={1996},
  volume={8 9},
  pages={
          1463-6
        }
}
In this study we determined TCR alpha and beta chain nucleotide sequences of HLA-Cw* 1601-restricted cytoxic T lymphocyte (CTL) clones obtained from the peripheral blood lymphocytes (PBL) of a melanoma patient. These clones were previously shown to be involved in the recognition of melanoma-associated antigenic epitopes SAYGEPRKL and AARAVFLAL encoded by gene MAGE-1 and BAGE respectively. All (3/3) anti-MAGE-1 CTL clones displayed TCRBV5 usage and one clonotype was found twice, > 1 year apart… 

Figures and Tables from this paper

Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients
TLDR
Contrary to what observed for public anti-Melan-A T- cell receptor alpha motifs, the unexpectedly high contribution of a public TRB motif in the recognition of a dominant melanoma epitope in melanoma patients may provide important information about the biology of anti-tumor T-cell responses and improve monitoring strategies ofAnti-Tumor vaccines.
Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clones.
TLDR
The identification of the HTMEVTVYHR peptide will extend to HLA-A*6801 melanoma patients the possibility to exploit gp100/pMel17 melanosomal protein for experimental and clinical studies.
Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination.
TLDR
Results indicate that TCR repertoire analysis at the tumor site facilitates the detection of T cell responses elicited by a vaccine and potentially cytotoxic for the autologous tumor.
T cell receptor usage in malignant diseases
TLDR
The data discussed here support the view that tumor-reactive T cells may accumulate locally at the tumor site, and the need for more knowledge about mechanisms of escape from immunosurveillance and suppression of a tumor-specific immune response in patients is indicated.
Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries
Unlike HLA-A and HLA-B, few peptide epitope motifs have been reported for HLA-C molecules. However, a number of cytotoxic T-lymphocyte epitopes derived from tumor antigens that bind to HLA-C
Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.
TLDR
Results indicate that vaccination with autologous, DNP-modified melanoma cells can expand selected clones of T cells at the tumor site and that such clones are potentially destructive to the tumor.
Immunogenicity without immunoselection: a mutant but functional antioxidant enzyme retained in a human metastatic melanoma and targeted by CD8(+) T cells with a memory phenotype.
TLDR
A new unique tumor antigen generated by a point mutation in the peroxiredoxin 5 (Prdx5) gene in an HLA-A*0201(+) human metastatic melanoma lacking the wild-type allele is identified and may be retained in all metastatic cells possibly as result of the relevant cellular function exerted by the mutated protein.
αβ T-cell receptor bias in disease and therapy (Review).
TLDR
The role of TCR repertoire bias in some diseases, and its application for therapeutic interventions, are outlined, as these play significant roles in disease progression, even with patients with a good prognosis.
Restricted T-cell receptor repertoire in melanoma metastases regressing after cytokine therapy.
TLDR
The finding indicates that the T-cell response in regressing melanoma lesions is dominated by T cells directed toward a limited number of epitopes and that epitope-specific T cells frequently use a highly restricted TCR repertoire.
...
1
2
3
...

References

SHOWING 1-10 OF 32 REFERENCES
Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
TLDR
Results indicate that a selective repertoire of TCR genes is used in anti-melanoma responses when the response is narrowed to major histocompatibility complex-restricted antigen-specific interactions.
Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment
TLDR
The studies reveal the dependence of this natural human immune response on a particular TCR gene segment and determine the expression of V beta 17 during the development of M58- 66-specific CTL lines in 21 unrelated HLA-A0201 subjects.
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus
TLDR
It is shown that identical TCR protein sequences are used by clones from each of four healthy unrelated virus carriers; a clone from a fifth varied conservatively at only two residues, suggesting that a persistent viral infection can select for a highly focused memory response and indicates a strong bias in gene segment usage and recombination.
Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1
TLDR
A long-lasting diversity in terms of fine specificity and of T cell antigen receptor structure in the repertoire of antitumor CTL derived from the blood of a melanoma patient and directed against a defined tumor antigen is indicated.
Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
TLDR
This study is the first report of TCR sequences specific for a melanoma epitope, and provides direct evidence that the immune system can provide more than one TCR capable of recognizing a TAA epitope.
Conservation of T cell receptor usage by HLA B27‐restricted influenza‐specific cytotoxic T lymphocytes suggests a general pattern for antigen‐specific major histocompatibility complex class I‐restricted responses
TLDR
This study shows that peptide‐specific HLA B27‐restricted CTL following influenza virus infection use very similar TcR and, when considered with previous studies, suggests a pattern of T cell receptor conservation for major histocompatibility complex class I‐restricted responses.
Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire
TLDR
Evidence is provided that the observed high degree of HIV-1-specific CTL activity may be due to monoclonal or oligoclonals expansion of specific effector cells, and that progeny of a particular CTL clone may persist for prolonged periods in vivo in the presence of a chronic productive viral infection.
In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset
TLDR
Results indicate that large clonal size and persistence are distinctive features of alpha/beta DN cells specific for bacterial antigens, may use antigen-presenting cells, restriction molecules, and selection routes different from those used by antigen- specific CD4+ T cells.
Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601
TLDR
The identification of a gene, named MAGE‐1, which codes for antigen MZ2‐E which is presented by HLA‐A1 is reported and the range of tumor patients who could be eligible for immunization against MAGE antigens is extended.
In Vivo Persistence of Expanded Clones Specific for Bacterial Antigens within the Human T Cell Receptor ce//~ CD4-8- Subset By Paolo Dellabona,* Giulia Casorati,* Brigitte Friedli,
TLDR
Results indicate that large clonal size and persistence are distinctive features of c~/fl DN cells specific for bacterial antigens and may use antigen-presenting cells, restriction molecules, and selection routes different from those used by antigen-specific CD4 + T cells.
...
1
2
3
4
...